Rik Ossenkoppele
21 – 30 of 171
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Fluid Biomarker Changes After Amyloid-β–Targeting Drugs
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
(
- Contribution to journal › Article
-
Mark
Personal social network strengthens adherence to lifestyle changes in individuals with subjective cognitive decline
(
- Contribution to journal › Article
-
Mark
Survey among experts on the future role of tau-PET in clinical practice and trials
(
- Contribution to journal › Article
-
Mark
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
(
- Contribution to journal › Article
-
Mark
The implications of amyloid-β pathology : only time will tell
(
- Contribution to journal › Article
-
Mark
Clinical recognition of frontotemporal dementia with right anterior temporal predominance : A multicenter retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders : An International, Multicenter Study
(
- Contribution to journal › Article
-
Mark
The impact of tau-PET in a selected memory clinic cohort : rationale and design of the TAP-TAU study
(
- Contribution to journal › Article
-
Mark
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
(
- Contribution to journal › Article